Headline
The latest stories from AHA Today.
Abbott Molecular Inc. issued a recall for its Alinity m SARS-CoV-2 AMP Kits and Alinity m Resp-4-Plex AMP Kits, distributed between May 13, 2020, and Aug. 31, 2021, for their potential to give false positive results.
The Centers for Disease Control and Prevention released an operational planning guide for pediatric COVID-19 vaccination and preliminary information on the pediatric Pfizer COVID-19 vaccine.
Available data support the safety and effectiveness of the Johnson & Johnson COVID-19 vaccine for emergency use authorization as a booster dose in individuals aged 18 and older at least two months after an initial single dose, the Food and Drug Administration’s Vaccines and Related Biological…
A Food and Drug Administration advisory panel voted unanimously to recommend an extra Moderna booster dose for certain individuals.
GE Healthcare Partners, in partnership with Oregon-based Apprise Health Insight, launched a first-of-its-kind tool for addressing hospital capacity and critical resource management.
Hospitals and health systems must move from “doing digital” to “being digital” to compete in a rapidly evolving environment, writes Cynthia Perazzo, executive vice president of insights and advisory, at AVIA.
The AHA, joined by the Federation of American Hospitals, Michigan Health & Hospital Association, Kentucky Hospital Association, Ohio Hospital Association and Tennessee Hospital Association urged the U.S. Supreme Court to review and rectify a 6th Circuit Court of Appeals decision that will…
The AHA released the latest edition of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The AHA continues to spotlight the important work of rural hospitals tasked with caring for the nearly 60 million Americans who live in rural communities.
The Food and Drug Administration and Magellan Diagnostics Inc. expanded the ongoing recall of LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests distributed between Oct. 27, 2020, and Aug. 19, 2021.